Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Feb 23.
Published in final edited form as: Genes Immun. 2009 Dec;10(Suppl 1):S5–S15. doi: 10.1038/gene.2009.85

Overview of the Rapid Response data

WM Brown 1, JJ Pierce 1, JE Hilner 2, LH Perdue 1, K Lohman 1, L Lu 1, PIW de Bakker 3, K Irenze 3, L Ziaugra 3, DB Mirel 3; the Type I Diabetes Genetics Consortium
PMCID: PMC2826989  NIHMSID: NIHMS163332  PMID: 19956101

Abstract

The Type I Diabetes Genetics Consortium (T1DGC) Rapid Response Workshop was established to evaluate published candidate gene associations in a large collection of affected sib-pair (ASP) families. We report on our quality control (QC) and preliminary family-based association analyses. A random sample of blind duplicates was analyzed for QC. Quality checks, including examination of plate-panel yield, marker yield, Hardy–Weinberg equilibrium, mismatch error rate, Mendelian error rate, and allele distribution across plates, were performed. Genotypes from 2324 families within nine cohorts were obtained from a panel of 21 candidate genes, including 384 single-nucleotide polymorphisms on two genotyping platforms performed at the Broad Institute Center for Genotyping and Analysis (Cambridge, MA, USA). The T1DGC Rapid Response project, following rigorous QC procedures, resulted in a 2297 family, 9688 genotyped individual database on a single-candidate gene panel. The available data include 9005 individuals with genotype data from both platforms and 683 individuals genotyped (276 in Illumina; 407 in Sequenom) on only one platform.

Keywords: type I diabetes, candidate gene, SNP, quality control, association

Introduction

The Type I Diabetes Genetics Consortium (T1DGC; http://www.t1dgc.org) is an international effort to identify genes that determine an individual’s risk of type I diabetes (T1D). The creation of a resource base of well-characterized affected sib-pair (ASP) families and other collections has been implemented that will facilitate the localization and characterization of T1D genes that determine disease risk. The aim of the T1DGC Rapid Response project was to explore candidate genes previously reported to be associated with T1D (for example INS,1 CTLA4,2 PTPN22,3 SUMO44). Confirmation of candidate genes for T1D has been difficult for some but not for others. Although many of the initial studies were underpowered, some genes appeared to exhibit their association only in certain populations or ethnic groups.

In the T1DGC Rapid Response experiment, a series of candidate genes were chosen for evaluation in a large collection of Caucasian ASP families. The candidate genes had been published earlier with identified polymorphisms that suggested association and may (or may not) have been replicated in other studies. In a separate component of the project, candidate genes that emerged from recent genome-wide association scans for T1D, type II diabetes, and other autoimmune diseases were included for follow-up. This report provides the background of the quality control (QC) procedures in the first Rapid Response experiment, whose objectives were to (1) establish evidence of replication of published candidate genes and (2) test hypotheses of population heterogeneity, the impact of stratification, potential genetic interaction on risk, and other modifying factors on T1D risk.

Results

The T1DGC Rapid Response project had three data-set releases. The second and third data-set releases resulted in modified, updated, and more complete versions of the earlier Rapid Response data. The main modifications for each release were incorporation of re-called markers and resolution of problematic families. As major histocompatibility complex (MHC) fine mapping and genome-wide linkage scans were being performed on the same families, these additional data provided more specific relationship information to help resolve pedigree structure problems. All datasets were securely maintained in the T1DGC web site (http://www.t1dgc.org) with password-protected access. These and other T1DGC datasets are now available (https://www.t1dgc.org/views/vw_databases.cfm).

The initial data release (2007.03.RR) consisted of 2317 families from 9 cohorts with genotype data on 21 candidate genes as well as a set of DNA fingerprinting markers. For this release, seven families were removed because of high levels of Mendelian inconsistencies. In addition, 135 individuals had either a pedigree change (that is classified new parent, sample switch, or gender reclassification) or were considered unrelated to other family members. The number of single-nucleotide polymorphisms (SNPs) genotyped per candidate gene ranged from 1 to 66. There were 357 SNPs released that were genotyped using the Illumina GoldenGate assay and 375 SNPs that were genotyped using the Sequenom platform; 334 SNPs were common to the two platforms. The Sequenom genotyping resulted in a slightly higher number of inconsistencies within families. Two SNPs were eliminated in the Illumina panel, as they resulted in problems in >20% of the families. Four SNPs were set to missing in the Sequenom panel that resulted in problems in >10% of the families. In addition, eight SNPs genotyped with the Illumina assay and two SNPs genotyped with the Sequenom assay were missing because of <80% call rate.

The second data release (2007.12.RR) were generated on 2297 families from 9 cohorts on 21 candidate genes and included DNA fingerprinting markers and re-genotyped data for seven SNPs on the Sequenom platform. These seven SNPs (INS rs1003483; PTPN22 rs1746860; IL13 rs1881457; IL12B rs2569253; IL4R rs3024613; IL2RA rs4147359; VDR rs7975232) had their data re-scored based on significant deviation from Hardy–Weinberg equilibrium assumptions. It was also determined that these seven SNPs had a low genotyping concordance compared with that observed on the Illumina panel. Thus, these SNPs were determined to have erroneously scored genotypes. The repeated scoring resulted in releasing 377 markers on the Sequenom platform and increasing the number to 336 SNPs that were scored on both platforms.

Earlier, the datasets that were released included all SNPs (regardless of genotyping status), three families whose Mendelian inconsistencies were resolved, elimination of one member from a pair of monozygotic twins, and removal of 23 duplicate families. This dataset incorporated 137 individuals who had either a pedigree change (that is classified new parent, sample switch, or gender reclassification), were members of a family who were determined to be unrelated, or were a duplicate sample and, therefore, had their genotype dataset to ‘missing.’

The third and final data release (2008.07.RR) consisted of 2297 families from 9 cohorts with genotype data on 21 candidate genes and a set of DNA fingerprinting markers (Table 1). For this release, the raw genotype data generated from the Sequenom platform were scored using the new Typer 4.0 software. A comparison of scoring 10 SNPs that were considered ‘poor performing’ markers and a second comparison of 20 SNPs using Typer 4.0 software suggested that well-called SNPs remained so, whereas poorly called SNPs improved when scored with the Typer 4.0 software. The Sequenom assay for TCF7 rs5742913 was originally designed to detect C and T alleles in dbSNP using ss65832708 (http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=5742913). This assay resulted in the SNP appearing monomorphic for the C allele; however, earlier data5,6 reported that the correct alleles are C and A (not T) as defined by ss93257904. By virtue of the Sequenom iPLEX chemistry use of four mass-distinct chain-terminating nucleotides, a re-definition by the Typer 4.0 software to identify and measure the mass peak corresponding to the A-extended primer (earlier attempting to detect the absent T-extended primer) permitted the accurate re-call of genotypes. To provide consistent data, all SNPs in the Sequenom dataset were recalled using Typer 4.0 software. These data were then subjected to standard QC procedures. The Illumina data were unchanged from the earlier release (2007.12.RR).

Table 1.

Description of T1DGC Rapid Response data following QC procedures

T1DGC
2008.07.RR
Data characteristics
Family summary: post-modification
Contributor Families in dataset Families with genotype data Families (n (%)) with
Parents
Affected full siblings
0 1 2 0 1 2 3 4+ Half sib
Asia-Pacific 191 191 27 53 111 1 11 168 8 1 2
BDA 417 417 6 71 340 6 63 347 1 0 0
Danish 146 146 17 41 88 1 18 115 12 0 0
Europe 475 475 51 114 310 0 30 420 22 1 2
HBDI 431 431 1 40 390 0 24 365 35 6 1
North America 334 334 38 103 193 0 28 293 10 0 3
United Kingdom 114 114 5 24 85 0 6 104 3 1 0
Joslin 112 111 38 24 49 1 12 90 5 0 3
Sardinian 78 78 4 22 52 0 8 70 0 0 0
All 2298 2297 187 492 1618 9 200 1972 96 9 11

Abbreviations: BDA, British Dietetic Association; HBDI, Human Biological Data Interchange; QC, quality control; TIDGC, Type I Diabetes Genetics Consortium.

Discussion

The T1DGC Rapid Response project resulted in a dataset containing 9688 individuals from 2297 ASP families with family members genotyped for 21 T1D candidate genes on two genotype platforms. Five of the candidate genes were ‘fully investigated,’ in that the structure of the gene was evaluated using tagging SNPs. Sixteen of the genes were subjected to genotyping using only the reported SNPs that exhibited the strongest association with T1D (for more detail, see Julier et al.,7 this volume). In this dataset, there are 9005 individuals with genotype data derived from both platforms. There are 683 individuals genotyped only on one platform (276 in Illumina; 407 in Sequenom).

There are two important aspects of the Rapid Response project. The first was that a majority of the families were included in a genome-wide linkage scan panel (6000 SNPs).8,9 Second, all families were included in the MHC Fine Mapping project.10 As a result of the additional genetic information, the T1DGC Coordinating Center was able to better resolve QC issues (such as questionable family structure) within the Rapid Response dataset. The T1DGC Rapid Response project permitted the creation of a valuable resource of well-characterized families from multiple geographic sites that showed the localization and characterization of T1D genes.

Materials and methods

Genotyping

The T1DGC Molecular Technology Subcommittee established a list of genes for investigation at the Rapid Response Laboratory (Broad Institute of Harvard/Massachusetts Institute of Technology). An initial set of published candidate genes and associated SNPs was selected, based on a literature search. Two lists of candidate genes were constructed for consideration in the experiment. List 1 included those genes (INS, PTPN22, CTLA4, IL2R/CD25, and SUMO4) that had been confirmed or replicated, excluding those in the MHC. List 2 included those genes (IL12B, IL4R, IL4, IL13, OAS1, VDR, SDF1, PAX4, FOXP3, IRS1, TCF7, IFIH1, EFHB, CAPSL, Q7Z4C4(5Q), and CEACAM21) that had not been replicated earlier.

From the initial set of candidate genes, a panel of 384 SNPs was identified using the ‘Tagger’ algorithm11 such that all observed SNPs in HapMap-CEU with minor allele frequency >3% were captured with a perfect proxy (r2 = 1) for genes on List 1, or with a tagging SNP at r2≥0.8 for genes on List 2. SNPs were preferentially chosen with high-design scores for the Illumina GoldenGate assay.

The panel of 384 SNPs was genotyped on two platforms, using the Illumina GoldenGate assay and the Sequenom MALDI-TOF assay. A preliminary round of design and assay testing using the HapMap CEU sample panel was performed on both platforms. For genotyping using the Sequenom platform, 19 SNPs were not included because of an inability to design robust assays. The 19 excluded SNPs were replaced with 16 SNPs potentially useful for sample tracking for Affymetrix whole-genome genotyping. The 381 SNPs genotyped using the Sequenom iPLEX technology were distributed among 20 iPLEX pools (13–21 SNPs/pool; median pool size 19). The SNPs were part of 21 candidate genes: 5 fully investigated (158 SNPs) and 16 replicated (226 SNPs). The number of SNPs genotyped for each gene ranged from 1 to 69 SNPs. Four genes contained a single SNP; 3 genes contained 5–6 SNPs; 7 genes contained 10–16 SNPs; 4 genes contained 21–28 SNPs; 3 genes contained 37–42 SNPs; and one gene contained 69 SNPs.

In the Illumina assay, 367 SNPs were adequately genotyped, whereas the remaining 17 SNPs could not be accurately called and were considered ‘missing.’ For the Sequenom assay, all 381 SNPs were genotyped. For the genotyped SNPs, 8 in the Illumina panel and 2 in the Sequenom panel had <80% call rate and were set to ‘missing.’ Using strand information, genotypes were examined and calls were adjusted on the Sequenom panel to reflect the strand order of the Illumina panel. This procedure required ‘flipping’ genotype calls.

For the original release of the Rapid Response data, the Sequenom platform used Typer 3.0 software (http://www.sequenom.com (software no longer available)) to call genotypes. The Sequenom genotype data were later re-called using Typer 4.0 software (http://sequenom.com/Genetic-Analysis/Applications/iPLEX-Genotyping/iPLEX-Literature). This version of the Sequenom genotype calling software allows the simultaneous viewing and consistent clustering of multiple production plates of data, ensuring that genotype class definitions are stable across plates. (For a complete list of SNPs, see Appendix A)

Appendix A.

Rapid Response reference SNP list

Study Chromosome Gene Marker Physical position Illumina Sequenom
Full 1 PTPN22 rs3827733 114050631 Genotyped Genotyped
Full 1 PTPN22 rs3789602 114051793 Genotyped Genotyped
Full 1 PTPN22 rs1217379 114056125 Genotyped Genotyped
Full 1 PTPN22 rs6537798 114063748 Genotyped Genotyped
Full 1 PTPN22 rs3789607 114078476 Genotyped Genotyped
Full 1 PTPN22 rs2476600 114081776 Genotyped Genotyped
Full 1 PTPN22 rs1217395 114086477 Genotyped Ungenotyped
Full 1 PTPN22 rs1970559 114089190 Genotyped Ungenotyped
Full 1 PTPN22 rs2476601 114089610 Genotyped Genotyped
Full 1 PTPN22 rs1775759 114100846 Genotyped Genotyped
Full 1 PTPN22 rs3765598 114106505 Genotyped Genotyped
Full 1 PTPN22 rs11582409 114111475 Ungenotyped Genotyped
Full 1 PTPN22 rs1217418 114113273 Genotyped Genotyped
Full 1 PTPN22 rs1217414 114124709 Genotyped Genotyped
Full 1 PTPN22 rs17510162 114125773 Genotyped Genotyped
Full 1 PTPN22 rs2488457 114127410 Genotyped Genotyped
Full 1 PTPN22 rs1235005 114129479 Genotyped Genotyped
Full 1 PTPN22 rs6665194 114129885 Genotyped Genotyped
Full 1 PTPN22 rs1217384 114131802 Genotyped Genotyped
Full 1 PTPN22 rs12566340 114132370 Genotyped Genotyped
Full 1 PTPN22 rs7529353 114132504 Genotyped Genotyped
Full 1 PTPN22 rs7524200 114138866 Genotyped Genotyped
Full 1 PTPN22 rs1217423 114139335 Genotyped Genotyped
Full 1 PTPN22 rs1746860 114141382 Ungenotyped Genotyped
Full 1 PTPN22 rs2358994 114141503 Genotyped Genotyped
Full 1 PTPN22 rs1539438 114142398 Genotyped Genotyped
Full 1 PTPN22 rs1217394 114145701 Genotyped Genotyped
Full 1 PTPN22 rs1217393 114145988 Genotyped Ungenotyped
Full 2 CTLA4 rs231811 204539397 Genotyped Genotyped
Full 2 CTLA4 rs6741283 204540316 Genotyped Genotyped
Full 2 CTLA4 rs11571293 204543219 Genotyped Genotyped
Full 2 CTLA4 rs2162610 204544235 Genotyped Genotyped
Full 2 CTLA4 rs926169 204548258 Genotyped Genotyped
Full 2 CTLA4 rs11571290 204548647 Genotyped Genotyped
Full 2 CTLA4 rs231770 204554659 Genotyped Genotyped
Full 2 CTLA4 rs733618 204556450 Genotyped Genotyped
Full 2 CTLA4 rs11571316 204556595 Genotyped Genotyped
Full 2 CTLA4 rs16840252 204557025 Genotyped Genotyped
Full 2 CTLA4 rs11571317 204557514 Genotyped Genotyped
Full 2 CTLA4 rs5742909 204557853 Genotyped Genotyped
Full 2 CTLA4 rs231777 204559094 Genotyped Genotyped
Full 2 CTLA4 rs231779 204559993 Genotyped Genotyped
Full 2 CTLA4 rs3087243 204564425 Genotyped Ungenotyped
Full 2 CTLA4 rs1427676 204566672 Genotyped Genotyped
Full 2 CTLA4 rs231727 204567056 Genotyped Genotyped
Full 2 CTLA4 rs231731 204570036 Genotyped Genotyped
Full 2 CTLA4 rs11571300 204572273 Genotyped Genotyped
Full 2 CTLA4 rs960792 204574756 Ungenotyped Ungenotyped
Full 2 CTLA4 rs1365965 204577376 Genotyped Genotyped
Full 2 CTLA4 rs231757 204578993 Genotyped Genotyped
Full 2 CTLA4 rs231755 204579075 Genotyped Genotyped
Full 2 CTLA4 rs7600322 204579859 Genotyped Ungenotyped
Full 2 CTLA4 rs6748358 204582411 Genotyped Genotyped
Full 6 SUMO4 rs12204461 149743228 Genotyped Genotyped
Full 6 SUMO4 rs7742990 149746219 Genotyped Genotyped
Full 6 SUMO4 rs9373589 149748981 Genotyped Genotyped
Full 6 SUMO4 rs9404034 149753676 Genotyped Genotyped
Full 6 SUMO4 rs2789490 149756012 Genotyped Genotyped
Full 6 SUMO4 rs237032 149757865 Genotyped Genotyped
Full 6 SUMO4 rs237025 149763383 Genotyped Genotyped
Full 6 SUMO4 rs2789488 149766983 Genotyped Genotyped
Full 6 SUMO4 rs2789489 149769038 Genotyped Genotyped
Full 6 SUMO4 rs652921 149772539 Genotyped Genotyped
Full 6 SUMO4 rs366905 149776790 Genotyped Genotyped
Full 6 SUMO4 rs480034 149777123 Genotyped Genotyped
Full 6 SUMO4 rs236999 149781068 Genotyped Genotyped
Full 6 SUMO4 rs513923 149782364 Genotyped Genotyped
Full 6 SUMO4 rs9485389 149782907 Genotyped Genotyped
Full 10 IL2R/CD25 rs6602363 6076150 Genotyped Genotyped
Full 10 IL2R/CD25 rs7898880 6077559 Genotyped Genotyped
Full 10 IL2R/CD25 rs7911500 6077732 Genotyped Genotyped
Full 10 IL2R/CD25 rs17147986 6078484 Ungenotyped Genotyped
Full 10 IL2R/CD25 rs6602364 6078859 Genotyped Genotyped
Full 10 IL2R/CD25 rs1323653 6079064 Genotyped Genotyped
Full 10 IL2R/CD25 rs7477011 6080600 Genotyped Genotyped
Full 10 IL2R/CD25 rs10795731 6082040 Genotyped Genotyped
Full 10 IL2R/CD25 rs17322780 6082478 Genotyped Genotyped
Full 10 IL2R/CD25 rs10795733 6083484 Genotyped Genotyped
Full 10 IL2R/CD25 rs764851 6087950 Genotyped Genotyped
Full 10 IL2R/CD25 rs10795737 6089350 Genotyped Genotyped
Full 10 IL2R/CD25 rs12359875 6091113 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722608 6092847 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722605 6093169 Genotyped Genotyped
Full 10 IL2R/CD25 rs12244380 6093380 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722598 6095156 Genotyped Genotyped
Full 10 IL2R/CD25 rs9663421 6095610 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722596 6096300 Genotyped Genotyped
Full 10 IL2R/CD25 rs2386841 6097738 Genotyped Genotyped
Full 10 IL2R/CD25 rs7899538 6099904 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722588 6100439 Genotyped Genotyped
Full 10 IL2R/CD25 rs2274037 6102114 Genotyped Genotyped
Full 10 IL2R/CD25 rs2076846 6103259 Genotyped Genotyped
Full 10 IL2R/CD25 rs7093069 6103325 Genotyped Genotyped
Full 10 IL2R/CD25 rs11596355 6104187 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722574 6106468 Genotyped Genotyped
Full 10 IL2R/CD25 rs2031229 6106574 Genotyped Ungenotyped
Full 10 IL2R/CD25 rs2025345 6107694 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722561 6109899 Genotyped Genotyped
Full 10 IL2R/CD25 rs7910961 6117802 Genotyped Genotyped
Full 10 IL2R/CD25 rs6602391 6118038 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722521 6118802 Genotyped Ungenotyped
Full 10 IL2R/CD25 rs11256448 6119485 Ungenotyped Genotyped
Full 10 IL2R/CD25 rs7072398 6119852 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722518 6120643 Genotyped Genotyped
Full 10 IL2R/CD25 rs11256456 6120718 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722516 6121223 Genotyped Genotyped
Full 10 IL2R/CD25 rs4749924 6122402 Genotyped Genotyped
Full 10 IL2R/CD25 rs6602398 6122959 Genotyped Genotyped
Full 10 IL2R/CD25 rs4749926 6125318 Genotyped Genotyped
Full 10 IL2R/CD25 rs10905656 6126099 Genotyped Genotyped
Full 10 IL2R/CD25 rs942201 6126298 Genotyped Genotyped
Full 10 IL2R/CD25 rs706780 6127032 Genotyped Genotyped
Full 10 IL2R/CD25 rs1107345 6127301 Genotyped Genotyped
Full 10 IL2R/CD25 rs11256497 6127800 Genotyped Genotyped
Full 10 IL2R/CD25 rs791587 6128705 Genotyped Genotyped
Full 10 IL2R/CD25 rs791589 6129577 Genotyped Ungenotyped
Full 10 IL2R/CD25 rs791590 6130328 Genotyped Genotyped
Full 10 IL2R/CD25 rs10905669 6132099 Genotyped Genotyped
Full 10 IL2R/CD25 rs1323658 6134360 Genotyped Genotyped
Full 10 IL2R/CD25 rs2476491 6135416 Genotyped Genotyped
Full 10 IL2R/CD25 rs2256774 6137171 Genotyped Genotyped
Full 10 IL2R/CD25 rs706779 6138830 Genotyped Genotyped
Full 10 IL2R/CD25 rs706778 6138955 Genotyped Genotyped
Full 10 IL2R/CD25 rs2104286 6139051 Genotyped Ungenotyped
Full 10 IL2R/CD25 rs3134883 6140731 Genotyped Genotyped
Full 10 IL2R/CD25 rs3118470 6141719 Genotyped Genotyped
Full 10 IL2R/CD25 rs12722486 6143768 Genotyped Genotyped
Full 10 IL2R/CD25 rs7072793 6146272 Genotyped Genotyped
Full 10 IL2R/CD25 rs7073236 6146558 Genotyped Genotyped
Full 10 IL2R/CD25 rs4147359 6148445 Ungenotyped Genotyped
Full 10 IL2R/CD25 rs7089861 6150332 Genotyped Genotyped
Full 10 IL2R/CD25 rs7090512 6150835 Genotyped Genotyped
Full 10 IL2R/CD25 rs1887027 6153788 Genotyped Genotyped
Full 10 IL2R/CD25 rs4749955 6158972 Genotyped Genotyped
Full 10 IL2R/CD25 rs11594656 6162015 Genotyped Genotyped
Full 10 IL2R/CD25 rs12251307 6163501 Genotyped Genotyped
Full 10 IL2R/CD25 rs7100400 6164086 Genotyped Genotyped
Full 11 INS rs4244808 2119686 Genotyped Ungenotyped
Full 11 INS rs1003483 2124119 Genotyped Genotyped
Full 11 INS rs3741208 2126350 Ungenotyped Genotyped
Full 11 INS rs1004446 2126719 Genotyped Genotyped
Full 11 INS rs4320932 2128177 Genotyped Genotyped
Full 11 INS rs7924316 2130023 Genotyped Genotyped
Full 11 INS rs3842753 2137636 Ungenotyped Genotyped
Full 11 INS rs3842748 2137971 Genotyped Genotyped
Full 11 INS rs2070762 2142911 Genotyped Genotyped
Full 11 INS rs6356 2147527 Genotyped Genotyped
Full 11 INS rs10840490 2150393 Ungenotyped Genotyped
Full 11 INS rs10743149 2150751 Genotyped Genotyped
Full 11 INS rs10840491 2150966 Genotyped Ungenotyped
Full 11 INS rs7119275 2151386 Genotyped Genotyped
Full 11 INS rs10840495 2152413 Genotyped Ungenotyped
Full 11 INS rs4930046 2153724 Genotyped Ungenotyped
Full 11 INS rs4929966 2154012 Genotyped Genotyped
Full 11 INS rs11042978 2154994 Genotyped Genotyped
Full 11 INS rs11564710 2156905 Genotyped Genotyped
Full 11 INS rs6578993 2157739 Genotyped Genotyped
Full 11 INS rs11564709 2157914 Genotyped Genotyped
Replication 2 IFIH1 rs2111485 162936043 Genotyped Genotyped
Replication 2 IFIH1 rs1990760 162949558 Genotyped Genotyped
Replication 2 IFIH1 rs3747517 162954331 Genotyped Genotyped
Replication 2 IFIH1 rs3788964 163032987 Genotyped Genotyped
Replication 2 IFIH1 rs984971 163050028 Genotyped Genotyped
Replication 2 IFIH1 rs2068330 163062897 Genotyped Genotyped
Replication 2 IRS1 rs16822551 227407085 Genotyped Genotyped
Replication 2 IRS1 rs11683087 227412111 Genotyped Genotyped
Replication 2 IRS1 rs2251692 227415285 Genotyped Ungenotyped
Replication 2 IRS1 rs17208239 227423202 Genotyped Genotyped
Replication 2 IRS1 rs17208470 227429410 Genotyped Genotyped
Replication 2 IRS1 rs2435185 227461928 Genotyped Genotyped
Replication 2 IRS1 rs4675095 227477472 Genotyped Genotyped
Replication 2 IRS1 rs1801278 227486049 Genotyped Genotyped
Replication 2 IRS1 rs1801123 227486548 Genotyped Genotyped
Replication 2 IRS1 rs6725330 227492362 Genotyped Genotyped
Replication 2 IRS1 rs6725556 227492497 Genotyped Genotyped
Replication 2 IRS1 rs13018009 227493906 Genotyped Genotyped
Replication 2 IRS1 rs4675096 227494446 Genotyped Genotyped
Replication 2 IRS1 rs956115 227500069 Genotyped Ungenotyped
Replication 2 IRS1 rs957797 227502248 Genotyped Genotyped
Replication 2 IRS1 rs13417106 227509333 Genotyped Genotyped
Replication 3 EFHB rs2929366 19934760 Genotyped Genotyped
Replication 5 CAPSL rs1445898 35946286 Genotyped Genotyped
Replication 5 IL12B rs7730126 158662525 Genotyped Genotyped
Replication 5 IL12B rs1549922 158664126 Genotyped Genotyped
Replication 5 IL12B rs4921466 158665350 Genotyped Genotyped
Replication 5 IL12B rs6859018 158669570 Genotyped Genotyped
Replication 5 IL12B rs17875325 158673108 Genotyped Genotyped
Replication 5 IL12B rs3181225 158673201 Genotyped Genotyped
Replication 5 IL12B rs17875324 158673428 Ungenotyped Genotyped
Replication 5 IL12B rs3212227 158675528 Genotyped Genotyped
Replication 5 IL12B rs2853696 158677238 Genotyped Genotyped
Replication 5 IL12B rs919766 158680142 Genotyped Genotyped
Replication 5 IL12B rs2853694 158681666 Genotyped Genotyped
Replication 5 IL12B rs2569253 158683571 Genotyped Ungenotyped
Replication 5 IL12B rs3181219 158684717 Genotyped Genotyped
Replication 5 IL12B rs17875303 158685556 Genotyped Genotyped
Replication 5 IL12B rs1433048 158688423 Genotyped Genotyped
Replication 5 IL12B rs2546893 158688538 Genotyped Genotyped
Replication 5 IL12B rs2546890 158692478 Genotyped Genotyped
Replication 5 IL12B rs10052709 158693055 Genotyped Genotyped
Replication 5 IL12B rs7709212 158696755 Genotyped Genotyped
Replication 5 IL12B rs6868898 158696998 Genotyped Genotyped
Replication 5 IL12B rs17056704 158700244 Genotyped Genotyped
Replication 5 IL12B rs13188370 158701707 Genotyped Genotyped
Replication 5 IL12B rs17056705 158701831 Genotyped Genotyped
Replication 5 IL12B rs17056706 158703333 Genotyped Genotyped
Replication 5 IL12B rs953861 158705160 Genotyped Genotyped
Replication 5 IL12B rs4244437 158705695 Genotyped Genotyped
Replication 5 IL12B rs11747112 158707187 Genotyped Genotyped
Replication 5 IL13 rs2240032 132005026 Ungenotyped Genotyped
Replication 5 IL13 rs1881457 132020308 Ungenotyped Genotyped
Replication 5 IL13 rs1800925 132020708 Genotyped Genotyped
Replication 5 IL13 rs1295686 132023742 Genotyped Genotyped
Replication 5 IL13 rs20541 132023863 Genotyped Genotyped
Replication 5 IL4 rs848 132024399 Genotyped Genotyped
Replication 5 IL4 rs1295683 132026775 Genotyped Genotyped
Replication 5 IL4 rs2243210 132029285 Genotyped Genotyped
Replication 5 IL4 rs2243248 132036543 Genotyped Genotyped
Replication 5 IL4 rs2243250 132037053 Genotyped Genotyped
Replication 5 IL4 rs2227284 132040624 Genotyped Genotyped
Replication 5 IL4 rs2243263 132041198 Genotyped Genotyped
Replication 5 IL4 rs2243274 132042731 Genotyped Genotyped
Replication 5 IL4 rs11242122 132052607 Genotyped Genotyped
Replication 5 IL4 rs1468216 132064151 Genotyped Genotyped
Replication 5 Q7Z4C4(5Q) rs9127 96397921 Genotyped Genotyped
Replication 5 TCF7 rs30503 133465245 Genotyped Genotyped
Replication 5 TCF7 rs30500 133467775 Genotyped Genotyped
Replication 5 TCF7 rs30499 133469625 Genotyped Genotyped
Replication 5 TCF7 rs244948 133472960 Genotyped Genotyped
Replication 5 TCF7 rs5742913 133479582 Ungenotyped Genotyped
Replication 5 TCF7 rs244692 133480434 Genotyped Genotyped
Replication 5 TCF7 rs151822 133483860 Genotyped Genotyped
Replication 5 TCF7 rs152404 133486613 Genotyped Genotyped
Replication 5 TCF7 rs152406 133489485 Genotyped Genotyped
Replication 5 TCF7 rs249611 133492556 Ungenotyped Genotyped
Replication 5 TCF7 rs17653687 133495899 Genotyped Genotyped
Replication 7 PAX4 rs3779536 126827928 Genotyped Genotyped
Replication 7 PAX4 rs806213 126828941 Genotyped Genotyped
Replication 7 PAX4 rs3735640 126830289 Genotyped Genotyped
Replication 7 PAX4 rs806216 126831813 Genotyped Genotyped
Replication 7 PAX4 rs3824006 126835931 Genotyped Genotyped
Replication 7 PAX4 rs10229583 126840854 Genotyped Genotyped
Replication 7 PAX4 rs712701 126845139 Genotyped Genotyped
Replication 7 PAX4 rs327518 126845743 Genotyped Genotyped
Replication 7 PAX4 rs7801118 126857837 Genotyped Genotyped
Replication 7 PAX4 rs806187 126863590 Genotyped Genotyped
Replication 10 CXCL12 rs731336 44159260 Genotyped Genotyped
Replication 10 CXCL12 rs1147882 44166437 Genotyped Genotyped
Replication 10 CXCL12 rs266109 44170430 Genotyped Genotyped
Replication 10 CXCL12 rs1147879 44170656 Ungenotyped Genotyped
Replication 10 CXCL12 rs266108 44172126 Genotyped Genotyped
Replication 10 CXCL12 rs266105 44175669 Genotyped Genotyped
Replication 10 CXCL12 rs11595588 44175746 Genotyped Genotyped
Replication 10 CXCL12 rs17391002 44175933 Ungenotyped Genotyped
Replication 10 CXCL12 rs4948876 44176752 Genotyped Genotyped
Replication 10 CXCL12 rs11239011 44176969 Genotyped Genotyped
Replication 10 CXCL12 rs185545 44178846 Genotyped Genotyped
Replication 10 CXCL12 rs17156191 44179353 Genotyped Genotyped
Replication 10 CXCL12 rs266098 44181674 Genotyped Ungenotyped
Replication 10 CXCL12 rs10900029 44182226 Genotyped Genotyped
Replication 10 CXCL12 rs266093 44186214 Genotyped Genotyped
Replication 10 CXCL12 rs266092 44186281 Genotyped Genotyped
Replication 10 CXCL12 rs1801157 44188263 Genotyped Genotyped
Replication 10 CXCL12 rs197452 44190246 Genotyped Genotyped
Replication 10 CXCL12 rs266087 44191068 Ungenotyped Genotyped
Replication 10 CXCL12 rs2297630 44191554 Genotyped Genotyped
Replication 10 CXCL12 rs2839693 44194573 Genotyped Genotyped
Replication 10 CXCL12 rs4948878 44194827 Genotyped Genotyped
Replication 10 CXCL12 rs2839689 44195465 Genotyped Genotyped
Replication 10 CXCL12 rs3780891 44198719 Genotyped Genotyped
Replication 10 CXCL12 rs2839685 44201644 Ungenotyped Genotyped
Replication 10 CXCL12 rs1413519 44202567 Genotyped Genotyped
Replication 10 CXCL12 rs2861442 44204965 Genotyped Genotyped
Replication 10 CXCL12 rs754617 44206348 Genotyped Genotyped
Replication 10 CXCL12 rs7088285 44207935 Genotyped Genotyped
Replication 10 CXCL12 rs6593412 44208136 Genotyped Genotyped
Replication 10 CXCL12 rs1855531 44209658 Genotyped Genotyped
Replication 10 CXCL12 rs11595460 44211083 Genotyped Genotyped
Replication 10 CXCL12 rs1023264 44213762 Genotyped Genotyped
Replication 10 CXCL12 rs1023262 44213870 Genotyped Genotyped
Replication 10 CXCL12 rs1779384 44214449 Genotyped Genotyped
Replication 10 CXCL12 rs4948881 44216041 Genotyped Genotyped
Replication 10 CXCL12 rs1761325 44216995 Genotyped Genotyped
Replication 12 OAS1 rs3741982 111791701 Genotyped Genotyped
Replication 12 OAS1 rs12177 111798145 Genotyped Genotyped
Replication 12 OAS1 rs2240193 111798381 Genotyped Genotyped
Replication 12 OAS1 rs2240191 111798451 Genotyped Genotyped
Replication 12 OAS1 rs12309946 111798975 Genotyped Genotyped
Replication 12 OAS1 rs4766662 111808419 Genotyped Genotyped
Replication 12 OAS1 rs3741981 111811590 Genotyped Genotyped
Replication 12 OAS1 rs10774671 111819913 Genotyped Genotyped
Replication 12 OAS1 rs7135579 111829602 Genotyped Genotyped
Replication 12 OAS1 rs3803057 111831454 Genotyped Genotyped
Replication 12 OAS1 rs7967461 111832479 Genotyped Genotyped
Replication 12 VDR rs1859281 46502016 Genotyped Genotyped
Replication 12 VDR rs2544028 46502697 Genotyped Genotyped
Replication 12 VDR rs10747524 46509741 Genotyped Genotyped
Replication 12 VDR rs11608702 46515035 Genotyped Genotyped
Replication 12 VDR rs12721364 46517697 Genotyped Genotyped
Replication 12 VDR rs7968585 46518360 Genotyped Genotyped
Replication 12 VDR rs6580639 46518439 Genotyped Genotyped
Replication 12 VDR rs731236 46525024 Ungenotyped Genotyped
Replication 12 VDR rs7975232 46525104 Genotyped Genotyped
Replication 12 VDR rs11574113 46525167 Genotyped Genotyped
Replication 12 VDR rs1544410 46526102 Genotyped Genotyped
Replication 12 VDR rs11574085 46537061 Genotyped Genotyped
Replication 12 VDR rs11168267 46537809 Genotyped Genotyped
Replication 12 VDR rs11574077 46539194 Genotyped Genotyped
Replication 12 VDR rs2239182 46541678 Genotyped Genotyped
Replication 12 VDR rs2107301 46541837 Genotyped Genotyped
Replication 12 VDR rs2239180 46542313 Genotyped Genotyped
Replication 12 VDR rs2239179 46544033 Genotyped Genotyped
Replication 12 VDR rs11574066 46544902 Genotyped Genotyped
Replication 12 VDR rs12717991 46545393 Genotyped Genotyped
Replication 12 VDR rs886441 46549231 Genotyped Genotyped
Replication 12 VDR rs2189480 46550095 Genotyped Genotyped
Replication 12 VDR rs3819545 46551273 Genotyped Genotyped
Replication 12 VDR rs3782905 46552434 Genotyped Genotyped
Replication 12 VDR rs2239186 46555677 Genotyped Genotyped
Replication 12 VDR rs10735810 46559162 Genotyped Genotyped
Replication 12 VDR rs2254210 46559981 Genotyped Genotyped
Replication 12 VDR rs2238136 46563980 Genotyped Genotyped
Replication 12 VDR rs2853564 46564754 Genotyped Genotyped
Replication 12 VDR rs4760648 46566932 Genotyped Genotyped
Replication 12 VDR rs11168287 46571681 Genotyped Genotyped
Replication 12 VDR rs4328262 46571915 Ungenotyped Ungenotyped
Replication 12 VDR rs4237855 46573470 Ungenotyped Genotyped
Replication 12 VDR rs11574027 46573640 Genotyped Genotyped
Replication 12 VDR rs11574026 46574513 Genotyped Ungenotyped
Replication 12 VDR rs10875695 46579304 Genotyped Genotyped
Replication 12 VDR rs11168292 46579872 Genotyped Genotyped
Replication 12 VDR rs12721377 46581618 Genotyped Genotyped
Replication 12 VDR rs10783219 46581755 Genotyped Genotyped
Replication 12 VDR rs7299460 46582535 Genotyped Genotyped
Replication 12 VDR rs4760658 46582753 Genotyped Genotyped
Replication 16 IL4R rs2057768 27229596 Genotyped Genotyped
Replication 16 IL4R rs2107356 27230905 Genotyped Genotyped
Replication 16 IL4R rs6498012 27239475 Genotyped Genotyped
Replication 16 IL4R rs1110470 27243928 Ungenotyped Genotyped
Replication 16 IL4R rs4787948 27248560 Genotyped Genotyped
Replication 16 IL4R rs2283563 27253855 Ungenotyped Genotyped
Replication 16 IL4R rs3024530 27258188 Genotyped Ungenotyped
Replication 16 IL4R rs3024537 27260320 Genotyped Genotyped
Replication 16 IL4R rs1805010 27263704 Genotyped Genotyped
Replication 16 IL4R rs3024560 27264168 Genotyped Genotyped
Replication 16 IL4R rs3024571 27265428 Genotyped Genotyped
Replication 16 IL4R rs2301807 27265599 Genotyped Genotyped
Replication 16 IL4R rs3024578 27265852 Genotyped Genotyped
Replication 16 IL4R rs2239347 27266522 Genotyped Genotyped
Replication 16 IL4R rs3116578 27267337 Ungenotyped Genotyped
Replication 16 IL4R rs3024613 27271754 Genotyped Genotyped
Replication 16 IL4R rs3024614 27271846 Genotyped Genotyped
Replication 16 IL4R rs3024622 27272954 Genotyped Genotyped
Replication 16 IL4R rs4787423 27274835 Genotyped Genotyped
Replication 16 IL4R rs3024668 27279450 Genotyped Genotyped
Replication 16 IL4R rs2234897 27281113 Genotyped Genotyped
Replication 16 IL4R rs1805011 27281373 Genotyped Genotyped
Replication 16 IL4R rs1805012 27281465 Genotyped Genotyped
Replication 16 IL4R rs1805015 27281681 Genotyped Ungenotyped
Replication 16 IL4R rs1801275 27281901 Ungenotyped Genotyped
Replication 16 IL4R rs1805016 27282428 Genotyped Genotyped
Replication 16 IL4R rs1805014 27282530 Genotyped Ungenotyped
Replication 16 IL4R rs2074570 27282658 Ungenotyped Genotyped
Replication 16 IL4R rs8832 27283288 Genotyped Genotyped
Replication 16 IL4R rs3024685 27284411 Genotyped Genotyped
Replication 16 IL4R rs12102586 27285554 Genotyped Genotyped
Replication 16 IL4R rs4787956 27285750 Genotyped Genotyped
Replication 16 IL4R rs16976728 27289213 Genotyped Genotyped
Replication 16 IL4R rs4787426 27292232 Ungenotyped Genotyped
Replication 16 IL4R rs12445135 27293007 Genotyped Genotyped
Replication 16 IL4R rs4787427 27293895 Genotyped Genotyped
Replication 16 IL4R rs7191188 27296912 Genotyped Genotyped
Replication 16 IL4R rs6498015 27299125 Genotyped Genotyped
Replication 16 IL4R rs6498016 27299289 Genotyped Genotyped
Replication 16 IL4R rs2382722 27300127 Genotyped Genotyped
Replication 16 IL4R rs9944340 27301092 Genotyped Genotyped
Replication 16 IL4R rs6498017 27302359 Genotyped Genotyped
Replication 19 CEACAM21 rs2302188 46777713 Genotyped Genotyped
Replication X FOXP3 rs11796927 48844942 Genotyped Genotyped
Replication X FOXP3 rs2294016 48849899 Genotyped Genotyped
Replication X FOXP3 rs5952519 48851586 Genotyped Genotyped
Replication X FOXP3 rs3761548 48874612 Genotyped Genotyped
Replication X FOXP3 rs4824747 48885394 Genotyped Genotyped
Replication X FOXP3 rs5906761 48887202 Genotyped Genotyped
3 FINGERPRINT rs11130795 60873474 Ungenotyped Genotyped
3 FINGERPRINT rs39639 124861224 Ungenotyped Genotyped
4 FINGERPRINT rs6834736 57035453 Ungenotyped Genotyped
4 FINGERPRINT rs6841061 186374692 Ungenotyped Genotyped
6 FINGERPRINT rs4870405 156367804 Ungenotyped Genotyped
8 FINGERPRINT rs2014286 16951496 Ungenotyped Genotyped
8 FINGERPRINT rs1367972 62166007 Ungenotyped Genotyped
9 FINGERPRINT rs12682834 87292377 Ungenotyped Genotyped
11 FINGERPRINT rs1025412 14202872 Ungenotyped Genotyped
12 FINGERPRINT rs10748087 66481362 Ungenotyped Genotyped
13 FINGERPRINT rs1408229 36702353 Ungenotyped Genotyped
13 FINGERPRINT rs2639486 82495935 Ungenotyped Genotyped
15 FINGERPRINT rs12909691 91645766 Ungenotyped Genotyped
16 FINGERPRINT rs8045964 80374234 Ungenotyped Genotyped
20 FINGERPRINT rs6038115 5209132 Ungenotyped Genotyped
20 FINGERPRINT rs6512586 47734553 Ungenotyped Genotyped

Samples

DNA samples from members of 2324 ASP families obtained from nine cohorts were used for genotyping. The families selected consisted primarily of nuclear families with an ASP with T1D. A total of 9982 DNA samples were shipped. A total of 9985 samples were used in the genotyping on both platforms: 9982 production samples (including 339 QC duplicate samples) and 3 CEPH control samples. For the Illumina platform, 9479 of the production samples and 322 QC samples genotyped with >90% call rate on 367 SNPs. For the Sequenom platform, 9581 production samples and 315 QC samples genotyped at >90% call rate on 380 SNPs.

The initial QC procedure of the Coordinating Center consisted of reviewing the failed status of the SNPs and samples, based on reports from the genotyping facility. Using the production and duplicate QC samples, concordance rates were generated between the pairs. This rate was based on both samples having a called genotype for a given SNP. The total number of concordant SNPs was divided by the total number of SNPs where both samples had a called genotyped. ‘Missingness’ was also examined between the two samples. Samples that were discordant (that is concordance rate <96%) were reviewed within families to identify the sample with Mendelian consistency. For concordant samples, the sample that had the greatest number of called genotypes was preserved for analysis. If a production sample or QC sample failed genotyping, the sample that passed evaluation was preserved for analysis.

Genotypes from each of the two marker panels (Illumina and Sequenom) were reviewed initially as separate datasets. The results of each QC procedure were then compared across both analyses to detect similar (or different) problems. In each genotyping platform, there were 339 QC samples. In both panels, two (different) samples failed for both the production and QC genotyping. For the Illumina panel, nine samples failed the production sample but passed for the QC sample. For the Sequenom panel, 16 samples failed QC genotyping but passed for the production sample. Four failed samples were common to the two platforms. For the Illumina panel, 15 samples failed QC genotyping but passed the production sample. For the Sequenom panel, 21 samples failed QC genotyping but passed for the production sample.

The overall concordance rate in the Illumina platform between the production sample and QC sample was 98.6%. There were 10 samples with concordance <96%. Only one of these 10 samples had >80% of total SNPs genotyped. In the Sequenom platform, there were seven samples with concordance rate <96%. Three of these samples had >80% of total SNPs genotyped. Once the production and QC sample concordance and comparison estimates were made, family structures and genotypic data were used to check for Mendelian inconsistency, relationship misclassification, and existence of duplicate samples.

Families were examined for Mendelian inconsistencies to detect relationship misclassification using the Ped-Check12 software. After summarizing PedCheck results, the Coordinating Center enumerated ‘Mendelian Inconsistency Errors’ (MIE) within each family. If the total number of inconsistencies was >2% of the total number of SNPs, the family was considered to be problematic and individually reviewed. From these in-depth reviews, pedigrees were re-arranged, restructured, or individuals coded as missing all SNP genotypes. Results from both genotyping datasets were reviewed. As part of this QC procedure, individual SNPs were independently checked for excess MIE. If an SNP had MIE in >20% of families, the SNP was considered to be problematic and the entire set of SNP genotypes was coded as missing. SNPs with MIE counts of 10–20% were reviewed on an individual basis. To aid in detection of family structure problems for the MHC data, we used the PREST13 results from the T1DGC genome-wide linkage scans.6,8

The Coordinating Center reviewed pairwise comparisons within families and between families to detect potential duplicate samples. The identical by state (IBS) statistics for pairwise individuals were obtained using Graphical Relationship Representation software.14 For pairs of relatives that had IBS > 1.98, the data were reviewed to determine whether they were within families (that is twins or duplicate samples) or between families (that is same person belonging to two distinct families, multiple individuals common between two distinct families, or duplicate sample between families). In combination with the IBS information, MIE results were used to determine whether a sample switch or a duplicate sample had occurred. The Coordinating Center examined individuals and families across all genotyping datasets released earlier. Using these data, the Coordinating Center decided whether there were sample switches, relatedness issues, gender discrepancies, or duplicate samples (that is within families, across families, or twins). After all issues were resolved, datasets were assembled for final MIE checks and families were re-examined. Families that continued to exhibit high-MIE rates were removed from the dataset. The remaining families were deemed to have random MIE. A family that was deemed problematic and a reasonable solution was not available was completely removed from the analysis dataset. Once families were considered ‘clean,’ the family was included the final analysis data file (Table 2).

Table 2.

Description of the T1DGC Rapid Response genetic data

T1DGC
2008.07.RR
Pedigree summary
Data characteristics and preparation
Source DNA Filtered ILMN Filtered SQNM Modifications
Pedigree changes
Genotypes dropped
New relationship Added members Samples switched Sex difference Ungenotyped Problematic families removed Duplicate families removed Within family duplicates removed Valid marker count ILMN Valid marker count SQNM
Asia-Pacific 782 763 (97.6) 756 (96.7) 2 3 1 0 3 0 0 0 357 376
BDA 1808 1668 (92.3) 1646 (91.0) 5 2 2 3 50 3 5 1 357 377
Danish 686 678 (98.8) 636 (92.7) 4 1 1 0 6 1 0 0 357 377
Europe 1953 1941 (99.4) 1898 (97.2) 2 2 3 0 11 0 0 4 357 377
HBDI 2143 1959 (91.4) 2042 (95.3) 1 1 3 0 7 0 7 2 357 377
North America 1376 1323 (96.1) 1301 (94.5) 1 1 4 1 8 0 4 4 357 377
United Kingdom 484 442 (91.3) 459 (94.8) 0 0 0 2 8 0 2 6 357 377
Joslin 386 368 (95.3) 335 (86.8) 2 2 1 0 4 1 5 0 357 377
Sardinian 364 337 (92.6) 339 (93.1) 0 0 0 0 8 0 0 1 357 377
Total 9982 9479 (95.0) 9412 (94.3) 17 12 15 6 105 5 23 18

Abbreviations: BDA, British Dietetic Association; HBDI, Human Biological Data Interchange; TIDGC, Type I Diabetes Genetics Consortium.

Summary

The Coordinating Center for the T1DGC performed QC and initial family-based association analyses on data from two genotyping platforms (Illumina Golden Gate and Sequenom iPLEX) for the T1DGC Rapid Response project. A random sample of blind duplicates was evaluated for QC. DNA samples collected from participants were shipped to the genotyping laboratory from several T1DGC DNA Repository sites. Quality checks, including examination of plate-panel yield, marker yield, Hardy–Weinberg equilibrium, mismatch error rate, Mendelian error rate, and allele distribution across plates, were performed. Genotypes from 2324 families within nine cohorts were genotyped for 21 candidate genes (384 SNPs). The final data consisted of genotypes from 2297 families (9688 individuals) that enabled robust estimation of candidate gene effects on T1D risk.

Acknowledgments

This research uses resources provided by the Type I Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute (NHGRI), the National Institute of Child Health and Human Development (NICHD), and the Juvenile Diabetes Research Foundation International (JDRF), and supported by U01 DK062418. We appreciate the technical assistance of the entire CGA Illumina team as led by Jamie Moore, and of the Sequenom team (led by LZ), with particular thanks to Rob Borkowski and Cherylyn Smith. Genotyping was performed at the Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources.

Footnotes

Conflict of interest

The authors declare no conflict of interest.

References

  • 1.Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994;371:130–136. doi: 10.1038/371130a0. [DOI] [PubMed] [Google Scholar]
  • 2.Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506–511. doi: 10.1038/nature01621. [DOI] [PubMed] [Google Scholar]
  • 3.Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36:337–338. doi: 10.1038/ng1323. [DOI] [PubMed] [Google Scholar]
  • 4.Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet. 2004;36:837–841. doi: 10.1038/ng1391. [DOI] [PubMed] [Google Scholar]
  • 5.Noble JA, White AM, Lazzeroni LC, Valdes AM, Mirel DB, Reynolds R, et al. A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes. Diabetes. 2003;52:1579–1582. doi: 10.2337/diabetes.52.6.1579. [DOI] [PubMed] [Google Scholar]
  • 6.Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, et al. The candidate genes TAF5 L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet. 2007;8:71–85. doi: 10.1186/1471-2350-8-71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Julier C, Akolkar B, Concannon P, Morahan G, Nierras C. Pugliese A and the Type I Diabetes Genetics Consortium. The Type I Diabetes Genetics Consortium ‘Rapid Response’ family-based candidate gene study: strategy, genes selection, and main outcome. Genes Immun. 2009;10(Suppl 1):S121–S127. doi: 10.1038/gene.2009.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, et al. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes. 2005;54:2995–3001. doi: 10.2337/diabetes.54.10.2995. [DOI] [PubMed] [Google Scholar]
  • 9.Concannon P, Chen WM, Julier C, Morahan G, Akolkar B, Erlich HA, et al. Genome-wide scan for linkage to type 1 diabetes in 2,496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes. 2009;58:1018–1022. doi: 10.2337/db08-1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fine Mapping of the MHC Region for Type 1 Diabetes Genes. Proceedings of the Type 1 Diabetes Genetics Consortium MHC Fine Mapping Workshop; Washington, DC. 27–28 August 2007. . [Google Scholar]; Diabetes Obes Metab. 2009;11(Suppl 1):1–109. doi: 10.1111/j.1463-1326.2008.00996.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.de Bakker PIW, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217–1223. doi: 10.1038/ng1669. [DOI] [PubMed] [Google Scholar]
  • 12.O’Connell JR, Weeks DE. PedCheck: a program for identifying marker typing incompatibilities in linkage analysis. Am J Hum Genet. 1998;63:259–266. doi: 10.1086/301904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McPeek MS, Sun L. Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet. 2000;66:1076–1094. doi: 10.1086/302800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Abecasis GR, Cherny SS, Cookson WO, Cardon LR. GRR: graphical representation of relationship errors. Bioinformatics. 2001;17:742–743. doi: 10.1093/bioinformatics/17.8.742. [DOI] [PubMed] [Google Scholar]

RESOURCES